DK3680000T3 - Fremgangsmåder til oprensning af antistoffer - Google Patents

Fremgangsmåder til oprensning af antistoffer Download PDF

Info

Publication number: DK3680000T3
Authority: DK; Denmark
Prior art keywords: antibodies; purification; methods
Prior art date: 2013-03-15

Application number

DK19198005.1T

Other languages

English (en)

Inventor

Kent E Goklen

Eric J Suda

Antonio Raul Ubiera

Original Assignee

Glaxosmithkline Ip Dev Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-15

Filing date

2014-03-13

Publication date

2024-04-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50391244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3680000(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-13 Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd

2024-04-02 Application granted granted Critical

2024-04-02 Publication of DK3680000T3 publication Critical patent/DK3680000T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Peptides Or Proteins (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)

DK19198005.1T 2013-03-15 2014-03-13 Fremgangsmåder til oprensning af antistoffer DK3680000T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361787309P	2013-03-15	2013-03-15
EP14713926.5A EP2969098B1 (en)	2013-03-15	2014-03-13	Methods for purifying antibodies

Publications (1)

Publication Number	Publication Date
DK3680000T3 true DK3680000T3 (da)	2024-04-02

Family

ID=50391244

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK19198005.1T DK3680000T3 (da)	2013-03-15	2014-03-13	Fremgangsmåder til oprensning af antistoffer
DK14713926.5T DK2969098T3 (da)	2013-03-15	2014-03-13	Fremgangsmåder til oprensning af antistoffer

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK14713926.5T DK2969098T3 (da)	2013-03-15	2014-03-13	Fremgangsmåder til oprensning af antistoffer

Country Status (15)

Country	Link
US (3)	US10676503B2 (da)
EP (3)	EP4371996A3 (da)
JP (2)	JP6599773B2 (da)
KR (1)	KR102114021B1 (da)
CN (1)	CN105188872B (da)
AU (1)	AU2014229280B2 (da)
BR (1)	BR112015022321A2 (da)
CA (1)	CA2902287A1 (da)
DK (2)	DK3680000T3 (da)
ES (2)	ES2765206T3 (da)
IL (1)	IL240753B (da)
RU (1)	RU2651483C2 (da)
SG (1)	SG11201506494XA (da)
TW (1)	TWI625335B (da)
WO (1)	WO2014141150A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI625335B (zh)	2013-03-15	2018-06-01	Glaxosmithkline Intellectual Property (No. 2) Limited	純化抗體的方法
JP2016519145A (ja)	2013-05-15	2016-06-30	メディミューンリミテッド	組換え産生ポリペプチドの精製
ES2857582T3 (es)	2014-04-30	2021-09-29	Novo Nordisk As	Métodos para la purificación de proteínas mediante el uso de ácido caprílico
WO2016121701A1 (ja)	2015-01-26	2016-08-04	株式会社カネカ	免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
CN108064286A (zh)	2015-01-26	2018-05-22	株式会社钟化	突变型免疫球蛋白κ链可变区结合性肽
WO2017195638A1 (ja)	2016-05-09	2017-11-16	株式会社カネカ	抗体またはκ鎖可変領域含有抗体断片の精製方法
RU2759909C2 (ru)	2016-09-07	2021-11-18	Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед	Способы очистки антител
CN106939045B (zh) *	2017-05-01	2020-03-31	深圳市国创纳米抗体技术有限公司	一种单克隆抗体细胞培养液澄清的方法
CN108085358A (zh) *	2018-02-08	2018-05-29	保定冀中药业有限公司	一种犬细小病毒单克隆抗体IgG2b-Fab片段的制备方法
TW202000891A (zh) *	2018-03-07	2020-01-01	英商葛蘭素史克智慧財產發展有限公司	純化抗體之方法
TW202003555A (zh) *	2018-03-07	2020-01-16	英商葛蘭素史克智慧財產發展有限公司	用於純化重組多肽之方法
CN116234619A (zh) *	2020-08-18	2023-06-06	赛多利斯比亚分离有限责任公司	宿主细胞dna的金属亲和提取
CN114133446A (zh) *	2021-12-31	2022-03-04	方坦思(上海)生物医药有限公司	单克隆抗体的纯化方法
CN116179582A (zh) *	2022-09-27	2023-05-30	南京医事达生物科技有限公司	一种通用型基因重组蛋白质a亲和纯化填料制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57106673A (en)	1980-12-24	1982-07-02	Chugai Pharmaceut Co Ltd	Dibenzo(b,f)(1,4)oxazepin derivative
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
US5429746A (en) *	1994-02-22	1995-07-04	Smith Kline Beecham Corporation	Antibody purification
US6955917B2 (en)	1997-06-20	2005-10-18	Bayer Healthcare Llc	Chromatographic method for high yield purification and viral inactivation of antibodies
IL127127A0 (en)	1998-11-18	1999-09-22	Peptor Ltd	Small functional units of antibody heavy chain variable regions
EP1584242B1 (en) *	2001-06-01	2010-01-20	Upfront Chromatography A/S	Fractionation of protein containing mixtures
CA2457636C (en)	2001-08-10	2012-01-03	Aberdeen University	Antigen binding domains
CN100403028C (zh)	2002-05-31	2008-07-16	印度农业研究委员会	Bt-cry毒素的迅速检测
ES2407380T5 (es) *	2004-02-27	2017-07-07	Octapharma Ag	Procedimiento para proporcionar una preparación de anticuerpos purificada, sin riesgo respecto a virus
EP1786827A4 (en) *	2004-05-14	2008-10-29	Kirin Holdings Kk	PROCESS FOR IMMUNOGLOBULINE CLEANING
US8263750B2 (en) *	2006-03-16	2012-09-11	Amgen Inc.	Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
AR062711A1 (es)	2006-09-08	2008-11-26	Wyeth Corp	Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad
WO2008085988A1 (en) *	2007-01-05	2008-07-17	Amgen Inc.	Methods of purifying proteins
JP6147726B2 (ja) *	2011-03-29	2017-06-14	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅＬＬＣ	タンパク質精製のためのバッファー系
TWI625335B (zh) *	2013-03-15	2018-06-01	Glaxosmithkline Intellectual Property (No. 2) Limited	純化抗體的方法
JP2016519145A (ja)	2013-05-15	2016-06-30	メディミューンリミテッド	組換え産生ポリペプチドの精製
EP3683232A1 (en)	2013-09-13	2020-07-22	F. Hoffmann-La Roche AG	Methods and compositions comprising purified recombinant polypeptides

2014
- 2014-03-13 TW TW103108898A patent/TWI625335B/zh active
- 2014-03-13 RU RU2015136860A patent/RU2651483C2/ru active
- 2014-03-13 CA CA2902287A patent/CA2902287A1/en not_active Abandoned
- 2014-03-13 BR BR112015022321A patent/BR112015022321A2/pt not_active Application Discontinuation
- 2014-03-13 WO PCT/IB2014/059755 patent/WO2014141150A1/en not_active Ceased
- 2014-03-13 EP EP24155364.3A patent/EP4371996A3/en active Pending
- 2014-03-13 SG SG11201506494XA patent/SG11201506494XA/en unknown
- 2014-03-13 ES ES14713926T patent/ES2765206T3/es active Active
- 2014-03-13 JP JP2015562513A patent/JP6599773B2/ja active Active
- 2014-03-13 US US14/775,868 patent/US10676503B2/en active Active
- 2014-03-13 ES ES19198005T patent/ES2978309T3/es active Active
- 2014-03-13 CN CN201480016016.XA patent/CN105188872B/zh active Active
- 2014-03-13 AU AU2014229280A patent/AU2014229280B2/en not_active Ceased
- 2014-03-13 KR KR1020157029042A patent/KR102114021B1/ko active Active
- 2014-03-13 DK DK19198005.1T patent/DK3680000T3/da active
- 2014-03-13 EP EP19198005.1A patent/EP3680000B1/en active Active
- 2014-03-13 DK DK14713926.5T patent/DK2969098T3/da active
- 2014-03-13 EP EP14713926.5A patent/EP2969098B1/en active Active
2015
- 2015-08-23 IL IL240753A patent/IL240753B/en active IP Right Grant
2019
- 2019-10-03 JP JP2019182562A patent/JP7002511B2/ja active Active
2020
- 2020-05-13 US US15/931,062 patent/US12358945B2/en active Active
2025
- 2025-06-12 US US19/235,815 patent/US20250353878A1/en active Pending

Also Published As

Publication number	Publication date
EP4371996A3 (en)	2024-08-14
JP2016519052A (ja)	2016-06-30
ES2765206T3 (es)	2020-06-08
EP3680000B1 (en)	2024-03-13
EP2969098A1 (en)	2016-01-20
JP6599773B2 (ja)	2019-10-30
DK2969098T3 (da)	2020-01-27
IL240753A0 (en)	2015-10-29
SG11201506494XA (en)	2015-09-29
JP7002511B2 (ja)	2022-02-21
US12358945B2 (en)	2025-07-15
TW201522365A (zh)	2015-06-16
KR20150131235A (ko)	2015-11-24
EP4371996A2 (en)	2024-05-22
ES2978309T3 (es)	2024-09-10
CN105188872B (zh)	2019-01-15
EP3680000A1 (en)	2020-07-15
US10676503B2 (en)	2020-06-09
JP2020019795A (ja)	2020-02-06
CN105188872A (zh)	2015-12-23
US20250353878A1 (en)	2025-11-20
AU2014229280B2 (en)	2017-01-05
BR112015022321A2 (pt)	2017-07-18
IL240753B (en)	2021-01-31
AU2014229280A1 (en)	2015-10-01
TWI625335B (zh)	2018-06-01
US20200277330A1 (en)	2020-09-03
WO2014141150A1 (en)	2014-09-18
RU2651483C2 (ru)	2018-04-19
KR102114021B1 (ko)	2020-05-22
CA2902287A1 (en)	2014-09-18
US20160024146A1 (en)	2016-01-28
RU2015136860A (ru)	2017-04-28
EP2969098B1 (en)	2019-10-30

Publication	Publication Date	Title
DK3301115T3 (da)	2022-01-31	Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer
DK3043816T3 (da)	2019-10-14	Anti-b7-h1-antistoffer til behandling af tumorer
DK3611262T3 (da)	2021-01-25	Fremgangsmåder til sekvensering af immunrepertoire
DK3268390T3 (da)	2025-01-20	Fremgangsmåder til oprensning af bispecifikke antistoffer
DK2964315T3 (da)	2019-01-02	System til behandling af neuromotorisk dysfunktion
HUE048782T2 (hu)	2020-08-28	Immunoglobulin tisztítása elõtisztítási lépések alkalmazásával
DK3113858T3 (da)	2020-07-27	Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater
EP3083682C0 (en)	2024-04-17	DOUBLE SPECIFICITY ANTIBODIES
IL243311A0 (en)	2016-03-31	Novel antibody frameworks
DK3336106T3 (da)	2020-07-13	Anti-fcrh5-antistoffer
DK3134506T4 (da)	2026-02-16	Fremgangsmåder til oprensning af messenger rna
DK2970954T3 (da)	2019-01-02	Modifikation af polypeptider
DK3080100T3 (da)	2023-02-06	Hæmmere af lysinspecifik demethylase-1
DK3708583T3 (da)	2022-05-16	Ikke-fucosylerede anti-fgfr2iiib-antistoffer
DK3006568T3 (da)	2019-10-07	Fremgangsmåde til fremstilling af tagatose
DK3083540T3 (da)	2020-02-24	Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner
DK3454346T3 (da)	2021-11-01	Anordning til cylotronfremstilling af technetium-99m
CL2016001519A1 (es)	2017-02-17	Anticuerpos anti-tau(ps422) humanizados y métodos de utilización
DK2961388T3 (da)	2019-07-08	Kombinationer af lægemidler
DK3010352T3 (da)	2021-03-08	Fremgangsmåde til fremstilling af fodertilsætning
IL240753B (en)	2021-01-31	Methods for purifying antibodies
DK3010895T3 (da)	2017-11-20	Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK2962754T3 (da)	2021-06-21	Fremgangsmåde til fremstilling af co-shiftkatalysator
DK3068800T3 (da)	2019-10-21	FcRn-specifikke antistoffer
DK2961378T3 (da)	2019-11-25	Fremgangsmåder til behandlingen af mitochondrisk sygdom